Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Guess?, Inc. Announces Participation at the ICR Conference 2025
-
CCC Intelligent Solutions Completes Acquisition of EvolutionIQ
-
Amerant Bancorp Inc. to Announce Fourth Quarter 2024 Financial Results and Host Conference Call
-
Roam Unveils Innovations Redefining Sustainable Hydration at CES 2025
-
Hess Named to Dow Jones Sustainability Index and Wall Street Journal’s List of Top 250 Best Managed Companies
-
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Paladin Energy Ltd Investors to Inquire About Securities Class Action Investigation - PALAF
-
Equus Announces Appointments of Fraser Atkinson as Chairman and John J. May as Director
-
Pursuit Celebrates New Chapter by Ringing NYSE Opening Bell on January 7, 2025
-
Cboe Global Markets Reports Trading Volume for December and Full Year 2024
-
Donor Alliance Recognizes Eaglecrest High School & Teacher with 2024 Community of Excellence Award
-
BP Prudhoe Bay Royalty Trust Announces No Unit Payment for the Fourth Quarter of 2024, Termination of the Trust on December 31, 2024, Commencement of Winding-Up of the Trust, and Receipt of Notice Fro
-
DBM Global Inc. Announces Election of Mark Koolis as CFO
-
ONEOK Announces Two New Executive Leadership Appointments
-
DBM Global Inc. Announces Election of Mark Koolis as CFO
-
LG UNVEILS A DAY IN A LIFE WITH "AFFECTIONATE INTELLIGENCE" AT LG WORLD PREMIERE
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENPH
-
Pearl Diver Credit Company Inc. Announces Full Exercise of Overallotment Option on Offering of Series A Preferred Stock
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Nextracker, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NXT
-
GCC Closes Strategic Aggregates Acquisitions
-
Ansys and Synopsys Announce Agreement with Keysight Technologies for Sale of Ansys PowerArtist
-
Air Lease Corporation Announces Fourth Quarter and Year End 2024 Earnings Conference Call
-
InvestBev Announces Strategic Equity Investment in Renais Gin, Supporting the Growth of Premium UK Spirits Brand
-
Excelerate Energy Completes 3,000th LNG Ship-To-Ship Transfer Operation
-
EMX Announces Acquisition of a Royalty on the Chapi Copper Mine Property in Peru
-
Sotera Health Company Appoints Vincent K. Petrella as Lead Independent Director
-
Monster Energy's Freeski and Snowboard Athletes Claim Victories at Big Air Klagenfurt FIS World Cup
-
Teladoc Health to Participate in Upcoming Investor Conference
-
Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
-
Glacier Bancorp, Inc. Announces Fourth Quarter Earnings Release and Conference Call
-
"Toyota Woven City," a Test Course for Mobility, Completes Phase 1 Construction and Prepares for Launch
-
Kura Oncology Announces Senior Executive Promotions
-
Midland States Bancorp, Inc. to Announce Fourth Quarter 2024 Financial Results on Thursday, January 23
-
West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference
-
ASUR Announces Total Passenger Traffic for December 2024
-
eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Umoja Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
KEVIN B. HABICHT TO RETIRE AS EVP, CHIEF FINANCIAL OFFICER OF NNN REIT, INC.; VINCENT H. CHAO NAMED AS SUCCESSOR
-
Stoke Therapeutics to Host Webcast to Discuss Successful Global Regulatory Alignment for a Phase 3 Study of Zorevunersen as Potentially the First Disease Modifying Medicine for Dravet Syndrome
-
Semtech Announces Upcoming Investor Conference
-
On to Participate in Fireside Chat at the 2025 ICR Conference
-
MtronPTI Awarded over $10 Million Production Contract for a Major U.S. Defense Program
-
Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
-
Enovix Completes Site Acceptance Testing (SAT) of Fab2
-
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
-
MannKind Expands Executive Leadership Team
-
Travere Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Ultragenyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Kaiser Aluminum Corporation Announces New Chairman of the Board and Appointment of New Director Following Retirement of Previous Executive Chair
-
Torrent Capital Initiates a Position in Solana Cryptocurrency
